Noncoding RNAs in asthmatic airway smooth muscle cells

Eur Respir Rev. 2023 Apr 19;32(168):220184. doi: 10.1183/16000617.0184-2022. Print 2023 Jun 30.

Abstract

Asthma is a complex and heterogeneous airway disease caused by genetic, environmental and epigenetic factors treated with hormones and biologics. Irreversible pathological changes to airway smooth muscle cells (ASMCs) such as hyperplasia and hypertrophy can occur in asthmatic patients. Determining the mechanisms responsible is vital for preventing such changes. In recent years, noncoding RNAs (ncRNAs), especially microRNAs, long noncoding RNAs and circular RNAs, have been found to be associated with abnormalities of the ASMCs. This review highlights recent ncRNA research into ASMC pathologies. We present a schematic that illustrates the role of ncRNAs in pathophysiological changes to ASMCs that may be useful in future research in diagnostic and treatment strategies for patients with asthma.

Publication types

  • Review

MeSH terms

  • Asthma* / diagnosis
  • Asthma* / genetics
  • Asthma* / pathology
  • Cell Proliferation
  • Cells, Cultured
  • Humans
  • MicroRNAs* / genetics
  • Myocytes, Smooth Muscle / pathology

Substances

  • MicroRNAs